SEC Form 4 · accession 0001567619-18-007208
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Americas
Period of report
Nov 30, 2018
Accepted (ET)
Dec 3, 2018 · 12:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Nov 30, 2018 | M | 9,168 | $43.63 | A | 84,289 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Stock Option PlanF1 | $43.63 | Nov 30, 2018 | M | 9,168 | D | Mar 1, 2014 | Mar 1, 2020 | ResMed Commmon Stock | 9,168 | 0 | D |
Explanation of responses
- F1Represents date options first become exercisable. Options vest 1/3 annually on the grant anniversary.